Информационные технологии в медицине на фоне пандемии | partners | «Лечащий врач» – профессиональное медицинское издание для врачей Научные статьи lvrach.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lvrach.ru Daily Mail and Mail on Sunday newspapers.
Pharmaceutical Executive® Reveals Winners of the 2021 Emerging Pharma Leaders Awards
The global prestigious awards program recognizes 13 up-and-coming notable professional leaders paving the way for the future in the pharmaceutical and biotech industries.
News provided by
Share this article
CRANBURY, N.J., May 11, 2021 /PRNewswire/
Pharmaceutical Executive®, a multimedia platform for industry leaders to exchange experiences and insights about innovative business and marketing ideas, is pleased to officially announce the winners of the
2021 Emerging Pharma Leaders awards. The awards were presented to 13 accomplished executives during a virtual webcast held today at 11 a.m.
Pharm Exec profiles 13 diverse leaders vital to the future of the biopharma industry.
(1)
Vancouver, British Columbia (Newsfile Corp. - May 4, 2021) -
Alpha Cognition Inc. (TSXV: ACOG) ( Alpha Cognition , or the Company ), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce the appointment of Lauren D Angelo to Chief Commercial Officer. In this role, she will ensure the integrated commercial success of the company. Her initial focus will be to establish the company s commercial strategy to effectively advance and position Alpha Cognition s neurology pipeline, which includes leading all aspects of the U.S. commercial launch of the company s lead program, ALPHA-1062, pending regulatory approval.
Vancouver, British Columbia–(Newsfile Corp. – May 4, 2021) –
Alpha Cognition Inc. (TSXV: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce the appointment of Lauren D’Angelo to Chief Commercial Officer. In this role, she will ensure the integrated commercial success of the company. Her initial focus will be to establish the company’s commercial strategy to effectively advance and position Alpha Cognition’s neurology pipeline, which includes leading all aspects of the U.S. commercial launch of the company’s lead program, ALPHA-1062, pending regulatory approval.